| 000 | 01078 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514184923.0 | ||
| 264 | 0 | _c20040525 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1462-2416 | ||
| 024 | 7 |
_a10.1517/phgs.5.3.295.29835 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmit, Jan W A | |
| 245 | 0 | 0 |
_aGenetically defined hyperlipidemia. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cApr 2004 |
||
| 300 |
_a295-304 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 |
_aHyperlipidemias _xcomplications |
| 650 | 0 | 4 |
_aHyperlipoproteinemias _xdrug therapy |
| 650 | 0 | 4 |
_aHypertriglyceridemia _xdrug therapy |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aLipoproteins _xmetabolism |
| 650 | 0 | 4 |
_aSitosterols _xblood |
| 700 | 1 | _aDiamant, Michaela | |
| 773 | 0 |
_tPharmacogenomics _gvol. 5 _gno. 3 _gp. 295-304 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/phgs.5.3.295.29835 _zAvailable from publisher's website |
| 999 |
_c14813934 _d14813934 |
||